Home/Filings/4/0001209191-14-046136
4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-046136

CIK 0001009356operating

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 9:38 PM ET

Size

6.2 KB

Accession

0001209191-14-046136

Insider Transaction Report

Form 4
Period: 2014-07-01
DERBYSHIRE ADAM C
EVP Finance/CFO
Transactions
  • Tax Payment

    Common Stock

    2014-07-01$123.35/sh2,458$303,194197,700 total
Holdings
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
  • [F2]Options are 100% vested.

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001009356

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 9:38 PM ET
Size
6.2 KB